Loading clinical trials...

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients | Clinical Trials | Clareo Health

COMPLETEDNCT02039557

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the el...

Lead sponsor: Gamida Cell ltd•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment33

Start dateMay 2014

Last updatedOct 23, 2024

Condition

Patients Transplanted With NiCord/CordIn (Omidubicel)

Locations shown

UCSF Benioff Children's Hospital

Oakland, California

Loyola University, Cardinal Bernardin Cancer Center

Maywood, Illinois

Duke University Medical Center

Durham, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 23, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions